Clinical trial No longer in our active list Interventional Ages 18 and up

Comparing surgery and botulinum toxin for improving quality of life in stroke patients

Official title: SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS

Run by Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental · NCT06392633 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether surgery or botulinum toxin injections can help stroke patients feel better and improve their quality of life by reducing muscle stiffness in their arms.

More Stroke trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment44 (estimated)
SponsorFundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Academic / other
Locations1 site (Granada)
Trial IDNCT06392633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with upper limb spasticity due to stroke, who have had the condition for at least 12 months.

Probably not a fit

Patients who have not consented to surgical treatment or have severe comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of surgical treatment versus botulinum toxin injections for managing upper limb spasticity in stroke patients. It involves a randomized controlled design with two groups: one receiving surgery and the other receiving botulinum toxin. The study will assess various outcomes, including functionality, quality of life, sleep quality, anxiety, depression, and brain activity through Functional Magnetic Resonance Imaging at baseline and follow-up intervals of 6 and 12 months. Additionally, the economic impact of both treatment approaches will be analyzed.

Why it matters

Potential benefit: If successful, this study could provide a new treatment option that significantly improves the quality of life for stroke patients with upper limb spasticity.

How similar studies have gone: While traditional treatments like botulinum toxin are well-established, the surgical approach being tested is less commonly explored, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients of legal age, with spasticity in the upper limb due to stroke, with a minimum evolution time of 12 months, who, after being informed orally and in writing of the objectives of the study, sign the informed consent form (themselves or their legal representatives).

Exclusion Criteria:

* Absence of consent, refusal of possible surgical treatment, stroke evolution time of less than 12 months, anaesthetic risk (ASA) class IV or higher, presence of involuntary movements, inability to respond adequately to surveys, deformities that cannot be addressed by surgical treatment or inability to follow up for at least one year.

Where it's running

  • University of Granada
    Granada, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.